株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

代謝性疾患用医薬品の世界市場:抗糖尿病薬・抗甲状腺薬・その他の医薬品 (副甲状腺機能亢進症・下垂体機能低下症・副腎機能低下症)

Metabolic Disorders Drugs Global Market Report 2019

発行 The Business Research Company 商品コード 531331
出版日 ページ情報 英文 300 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.28円で換算しております。
Back to Top
代謝性疾患用医薬品の世界市場:抗糖尿病薬・抗甲状腺薬・その他の医薬品 (副甲状腺機能亢進症・下垂体機能低下症・副腎機能低下症) Metabolic Disorders Drugs Global Market Report 2019
出版日: 2019年01月01日 ページ情報: 英文 300 Pages
概要

当レポートでは、世界の代謝性疾患用医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、薬剤区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 代謝性疾患用医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 抗糖尿病薬
    • 抗甲状腺薬
    • その他
      • 副甲状腺機能亢進症
      • 下垂体機能低下症
      • 副腎機能低下症
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 代謝性疾患用医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • 高血圧の有病者数:国別
  • 世界の一般開業医の数:国別
  • 市場収益 vs 一般開業医数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • Novo Nordisk
  • Sanofi
  • Merck & Co.
  • Eli Lilly
  • Astrazeneca PLC

第18章 主要M&A:代謝性疾患用医薬品市場

第19章 市場背景:医薬品市場

第20章 医薬品産業のファイナンシャルマージン

第21章 付録

目次

Metabolic Disorders Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Metabolic Disorders Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.

Scope

Markets Covered: Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

Companies Mentioned: Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Metabolic Disorders Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Metabolic Disorders Drugs Market Regional Analysis

  • 9.1. Global Metabolic Disorders Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Metabolic Disorders Drugs Market Segmentation

  • 10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Anti Diabetics drugs
    • 10.1.2. Anti-Thyroid drugs
    • 10.1.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

11. Metabolic Disorders Drugs Market Metrics

  • 11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Metabolic Disorders Drugs Market

  • 12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview
  • 12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics
    • 12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.6. Asia-Pacific Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis
    • 12.7.1. China Metabolic Disorders Drugs Market
      • 12.7.1.1. China Metabolic Disorders Drugs Market Overview
      • 12.7.1.2. China Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Metabolic Disorders Drugs Market
      • 12.7.2.1. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Metabolic Disorders Drugs Market
      • 12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Metabolic Disorders Drugs Market
      • 12.7.4.1. India Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Metabolic Disorders Drugs Market
      • 12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Metabolic Disorders Drugs Market
      • 12.7.6.1. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Metabolic Disorders Drugs Market
      • 12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Metabolic Disorders Drugs Market
      • 12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Metabolic Disorders Drugs Market
      • 12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Metabolic Disorders Drugs Market
      • 12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Metabolic Disorders Drugs Market
      • 12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Metabolic Disorders Drugs Market
      • 12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Metabolic Disorders Drugs Market
      • 12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Metabolic Disorders Drugs Market

  • 13.1. Western Europe Metabolic Disorders Drugs Market Overview
  • 13.2. Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Metabolic Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.6. Western Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis
    • 13.7.1. Austria Metabolic Disorders Drugs Market
      • 13.7.1.1. Austria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Metabolic Disorders Drugs Market
      • 13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Metabolic Disorders Drugs Market
      • 13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Metabolic Disorders Drugs Market
      • 13.7.4.1. Finland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Metabolic Disorders Drugs Market
      • 13.7.5.1. France Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Metabolic Disorders Drugs Market
      • 13.7.6.1. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Metabolic Disorders Drugs Market
      • 13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Metabolic Disorders Drugs Market
      • 13.7.8.1. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Metabolic Disorders Drugs Market
      • 13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Metabolic Disorders Drugs Market
      • 13.7.10.1. Norway Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Metabolic Disorders Drugs Market
      • 13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Metabolic Disorders Drugs Market
      • 13.7.12.1. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Metabolic Disorders Drugs Market
      • 13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Metabolic Disorders Drugs Market
      • 13.7.14.1. Switzerland Metabolic Disorders Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Metabolic Disorders Drugs Market
      • 13.7.15.1. UK Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Metabolic Disorders Drugs Market

  • 14.1. Eastern Europe Metabolic Disorders Drugs Market Overview
  • 14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.6. Eastern Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Metabolic Disorders Drugs Market,
      • 14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Metabolic Disorders Drugs Market
      • 14.7.2.1. Poland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Metabolic Disorders Drugs Market
      • 14.7.3.1. Romania Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Metabolic Disorders Drugs Market
      • 14.7.4.1. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Metabolic Disorders Drugs Market

  • 15.1. North America Metabolic Disorders Drugs Market Overview
  • 15.2. North America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Metabolic Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.6. North America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Metabolic Disorders Drugs Market: Country Analysis
    • 15.7.1. Canada Metabolic Disorders Drugs Market
      • 15.7.1.1. Canada Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Metabolic Disorders Drugs Market
      • 15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Metabolic Disorders Drugs Market
      • 15.7.3.1. USA Metabolic Disorders Drugs Market Overview
      • 15.7.3.2. USA Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Metabolic Disorders Drugs Market

  • 16.1. South America Metabolic Disorders Drugs Market Overview
  • 16.2. South America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Metabolic Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.6. South America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Metabolic Disorders Drugs Market: Country Analysis
    • 16.7.1. Argentina Metabolic Disorders Drugs Market
      • 16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Metabolic Disorders Drugs Market
      • 16.7.2.1. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Metabolic Disorders Drugs Market
      • 16.7.3.1. Chile Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Metabolic Disorders Drugs Market
      • 16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Metabolic Disorders Drugs Market
      • 16.7.5.1. Peru Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Metabolic Disorders Drugs Market
      • 16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Metabolic Disorders Drugs Market

  • 17.1. Middle East Metabolic Disorders Drugs Market Overview
  • 17.2. Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Metabolic Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.6. Middle East Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Metabolic Disorders Drugs Market
      • 17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Metabolic Disorders Drugs Market
      • 17.7.2.1. Israel Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Metabolic Disorders Drugs Market
      • 17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Metabolic Disorders Drugs Market
      • 17.7.4.1. UAE Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Metabolic Disorders Drugs Market

  • 18.1. Africa Metabolic Disorders Drugs Market Overview
  • 18.2. Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Metabolic Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.6. Africa Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Metabolic Disorders Drugs Market: Country Analysis
    • 18.7.1. Egypt Metabolic Disorders Drugs Market
      • 18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Metabolic Disorders Drugs Market
      • 18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Metabolic Disorders Drugs Market
      • 18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

19. Metabolic Disorders Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Sanofi S.A
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.1.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Novo Nordisk A/S
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.2.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. AstraZeneca Plc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.3.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Johnson & Johnson
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.4.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Merck & Co
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.5.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Metabolic Disorders Drugs Market In 2022- Growth Countries
  • 22.2. Global Metabolic Disorders Drugs Market In 2022- Growth Segments
  • 22.3. Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top